Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400137 · ClinicalTrials.gov registry record · NA
IOP Elevation Study
A NA study of Intraocular Pressure, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03400137: Recruiting NA study of Intraocular Pressure, sponsored by NYU Langone Health.
NCT03400137 is a NA study of Intraocular Pressure that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 150 participants, above the 72-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (108% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03400137, a NA study of Intraocular Pressure, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to improve understanding of the pathophysiologic process that leads to the development of glaucamotous damage. The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased intraocular pressure (IOP) is a major risk factor. It is also thought that the LC is a site of primary damage during pathogenesis of the disease. This prospective study with determine the in-vivo mechanical response to IOP modulation at the level of the ONH and LC.
Primary Outcome
OCT scanning will be obtained at baseline and with increased IOP. The IOP elevation will last no longer than two minutes, during which scans will be acquired by the imaging device.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Increasing of intraocular pressure (IC)
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-03-07 |
| Est. Completion | 2024-05-08 |
| Phase | NA |
What NCT03400137 shows while recruiting
NCT03400137 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 72-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (108% higher).
The record links to 1 condition, with Intraocular Pressure appearing as the primary indexed condition, and to 1 intervention - of which Increasing of intraocular pressure (IC) is the first listed.
NCT03400137 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03400137 about?
NCT03400137 is a clinical study titled "IOP Elevation Study". The purpose of this study is to improve understanding of the pathophysiologic process that leads to the development of glaucamotous damage. The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased intraocular pressure (IOP) is a major risk factor. It is ...
What is the current status of trial NCT03400137?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2018-03-07. Estimated completion is 2024-05-08.
What conditions does trial NCT03400137 study?
This clinical trial studies the following conditions: Intraocular Pressure.
What interventions are being tested in trial NCT03400137?
The interventions under investigation include: Increasing of intraocular pressure (IC) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03400137?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03400137 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraocular Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03400137's enrollment target sits among peer trials
150 1st of 9 higher than 9 of 9 other Intraocular Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intraocular Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Raised End-Tidal pCo2 on Choroidal Volume
RECRUITING · NA
-
Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure
COMPLETED · NA
-
Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings
COMPLETED · NA
-
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
RECRUITING · Phase 4
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
-
Anterior Segment Optical Coherence Tomography Microstent Positioning
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI